21247 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13274)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (125)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21247)
  2. Survivorship Research (5130)
  3. Department of Medicine (4873)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4018)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (919)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II study of sorafenib with or without everolimus in patients with radioactive iodine refractory Hurthle cell thyroid cancer (HCC) (Alliance A091302/ ITOG 1706)
    Meeting Abstract

    Sherman, E. J.; Foster, N. R.; Su, Y. B.; Shergill, A.; Ho, A. L.; Konda, B.; Ghossein, R. A.; Ganly, I.; Schwartz, G. K.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Omics guided small molecule inhibitor screen for the identification of therapeutic vulnerabilities in metastatic lung adenocarcinoma
    Meeting Abstract

    Morris, B. B.; Gray, L. G.; Gentzler, R. D.; Jones, D. R.; Mayo, M. W.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Computational extraction and analysis of de-identified medical records to characterize hyperammonemia in patients with fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Zack, T.; Maisel, S.; O'Neill, A. F.; La Quaglia, M. P.; Herman, M.; Knox, J. J.; Yaqubie, A.; Venook, A. P.; Mayer, R. J.; Gordan, J. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma
    Meeting Abstract

    Amaria, R. N.; Postow, M. A.; Tetzlaff, M. T.; Ross, M. I.; Glitza, I. C.; McQuade, J. L.; Wong, M. K. K.; Gershenwald, J. E.; Goepfert, R.; Keung, E. Z. Y.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC)
    Meeting Abstract

    Yu, Y.; Schòˆder, H.; Kang, J.; McBride, S. M.; Tsai, C. J.; Chen, L.; Zakeri, K.; Gelblum, D. Y.; Boyle, J.; Cracchiolo, J. R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS)
    Meeting Abstract

    Crowley, F.; Cadoo, K. A.; Chiang, S.; Mueller, J. J.; Hensley, M. L.; O'Cearbhaill, R. E.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer
    Meeting Abstract

    Jee, J.; Lebow, E. S.; Murciano-Goroff, Y. R.; Jayakumaran, G.; Shen, R.; Brannon, A. R.; Benayed, R.; Namakydoust, A.; Offin, M.; Paik, P. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs)
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Morris, L. G. T.; Ostrovnaya, I.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Multidisciplinary consensus recommendations for the management of non-spine bone metastases: Results of a modified Delphi process in a community-academic partnership
    Meeting Abstract

    Mathis, N. J.; Yang, J. T.; Vaynrub, M.; Martin, E. S.; Kotecha, R.; Panoff, J.; Salner, A. L.; McIntosh, A. F.; Gupta, R.; Gulati, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save